Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sara Alonso-Álvarez, Maria Belén Vidriales, Maria Dolores Caballero, Oscar Blanco, Noemí Puig, Alejandro Martin, Maria Jesús Peñarrubia, Esther Zato, Josefina Galende, Abelardo Bárez, Miguel Alcoceba, Alberto Orfão, Marcos González & Ramón García-Sanz. (2017) The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy. Leukemia & Lymphoma 58:5, pages 1144-1152.
Read now
Read now
Runzhe Chen, Fei Wang, Hongming Zhang & Baoan Chen. (2015) Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies. Drug Design, Development and Therapy 9, pages 2277-2283.
Read now
Read now
Runzhe Chen & Baoan Chen. (2015) Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma. Drug Design, Development and Therapy 9, pages 1729-1733.
Read now
Read now
Articles from other publishers (5)
Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Asta Försti, Akseli Hemminki & Kari Hemminki. (2020) Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor. Cancer Medicine 9:21, pages 8258-8265.
Crossref
Crossref
Vít Procházka, Tomáš Papajík, Tereza Dýšková, Martin Dihel, Světlana Brychtová, Zuzana Prouzová, Eva Kriegová, Marie Lukášová & Veronika Hanáčková. (2019) The Lymphoma-Associated Macrophage to Hodgkin-Reed-Sternberg Cell Ratio Is a Poor Prognostic Factor in Classic Hodgkin Lymphoma Patients. Clinical Lymphoma Myeloma and Leukemia 19:10, pages e573-e580.
Crossref
Crossref
Peter Ugocsai, Daniel Wolff, Karin Menhart, Dirk Hellwig, Ernst Holler, Wolfgang Herr & Albrecht Reichle. (2016) Biomodulatory metronomic therapy induces PET-negative remission in chemo- and brentuximab-refractory Hodgkin lymphoma. British Journal of Haematology 172:2, pages 290-293.
Crossref
Crossref
Paul J. Br?ckelmann, Helen Goergen, Michael Fuchs, Jan Kriz, Robert Semrau, Christian Baues, Carsten Kobe, Karolin Behringer, Dennis A. Eichenauer, Bastian von Tresckow, Beate Klimm, Teresa Halbsguth, Diana Wongso, Annette Pl?tschow, Heinz Haverkamp, Markus Dietlein, Hans T. Eich, Harald Stein, Volker Diehl, Peter Borchmann & Andreas Engert. (2015) Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group. British Journal of Haematology 171:4, pages 547-556.
Crossref
Crossref
RONG FU, HONG YU, YU-HONG WU, HUI LIU & ZONG-HONG SHAO. (2015) Hodgkin's lymphoma associated with myelofibrosis: A case report. Oncology Letters 10:3, pages 1551-1554.
Crossref
Crossref